A new combination therapy against cancer has been investigated by a research team at the Medical University of Vienna led by Maria Sibilia. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod. This combination showed promising results in topically accessible tumors like melanoma and breast cancer models: The […]
Read More… from New combination immunotherapy against breast cancer










